List view / Grid view

Christian Schuler (Simon-Kucher & Partners)



Seven secret ingredients for successfully launching and commercialising a biopharma’s first drug in Europe

23 December 2020 | By

After the US, Europe is considered the second most attractive market for serving patient needs while realising commercial value from innovative drugs. However, the 27 EU member states each have their own approaches to pricing and market access – and need tailored commercialisation and go-to-market strategies. Simon-Kucher & Partners analysed…